New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ISRG;FLDM;CPHD From The Last 14 Days
Check below for free stories on ISRG;FLDM;CPHD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 22, 2014
16:39 EDTISRGIntuitive Surgical sees capital pressures in most hospitals to continue
Subscribe for More Information
16:17 EDTISRGIntuitive Surgical reports Q2 adjusted EPS $3.73, GAAP EPS $2.77
Consensus $2.83. Intuitive Surgical ended Q2 with $2B in cash, cash equivalents, and investments, a decrease of $920M during the quarter, primarily reflecting the impact of $1B utilized during the quarter to repurchase shares of its common stock.
16:13 EDTISRGIntuitive Surgical rises after results, first look
Subscribe for More Information
16:06 EDTISRGIntuitive Surgical reports Q2 EPS $2.77, consensus $2.83
Subscribe for More Information
15:30 EDTISRGNotable companies reporting after market close
Subscribe for More Information
13:57 EDTISRGEarnings Preview: Intuitive Surgical share price flat over last 12 months
Subscribe for More Information
11:36 EDTISRGIntuitive Surgical July weekly volatility increases into Q2 and outlook
Subscribe for More Information
July 18, 2014
09:44 EDTCPHDCepheid trades sharply lower after earnings, levels to watch
Subscribe for More Information
09:24 EDTCPHDOn The Fly: Pre-market Movers
Subscribe for More Information
07:37 EDTISRGIntuitive Surgical Q2 expectations 'appear achievable,' says Jefferies
Jefferies says its hospital and surgeon channel checks increase its comfort level around initial Xi demand and overall placements ahead of Intuitive Surgical's Q2 results, though the firm cautions that visibility on utilization is low and procedures could come in below consensus. Jefferies thinks expectations for Q2 "appear achievable" since they incorporate near-term challenges. The firm keeps a Buy rating on the stock with a $465 price target.
July 17, 2014
17:42 EDTCPHDCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
17:31 EDTCPHDCepheid sees significant step up in Q4 revenue
17:31 EDTCPHDCepheid sees Q3 non-GAAP EPS (1c)-1c, consensus (8c)
Subscribe for More Information
16:14 EDTCPHDCepheid sees FY14 adjusted EPS 10c-13c, may not compare to consensus (37c)
Subscribe for More Information
16:13 EDTCPHDCepheid reports Q2 EPS (14c), consensus (14c)
Reports Q2 revenue $116.5M, consensus $115.56M.
July 14, 2014
08:18 EDTCPHDCepheid Q2 results should beat expectations, says Wedbush
Wedbush thinks the high number of Cepheid's Infinity placements in 4Q13 and Q1 could boost the company's Q2 results. The firm keeps a $58 price target and Outperform rating on the shares.
July 10, 2014
14:29 EDTISRGT. Rowe Price reports 11.1% passive stake in Intuitive Surgical
Subscribe for More Information
10:59 EDTFLDMFluidigm expected to report strong quarter at Piper Jaffray
Subscribe for More Information
10:05 EDTCPHDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:05 EDTISRGIntuitive Surgical survey shows growing Japan momentum, says Jefferies
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use